Found: 3
Select item for more details and to access through your institution.
The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1555-8
- By:
- Publication type:
- Article
The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 538, doi. 10.1186/s12885-015-1555-8
- By:
- Publication type:
- Article
The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion.
- Published in:
- 2015
- By:
- Publication type:
- journal article